LILRB1功能性内含子变异与塞内加尔人群临床疟疾易感性相关
研究基于非洲eQTL数据筛选LILRB1调控变异,在267名塞内加尔疟疾或健康个体中基因分型,发现rs7246537的A等位基因携带者临床疟疾和脑型疟疾风险降低,荧光素酶实验证实A等位基因降低启动子活性,提示该功能性调控变异通过调节LILRB1表达影响疟疾易感性。
要点
- rs7246537的A等位基因与临床疟疾和脑型疟疾风险降低相关。
- 该变异位于YY1结合位点,A等位基因降低启动子活性。
- 抑制性免疫通路LILRB1可能是疟疾结局的重要决定因素。
核心结论
- rs7246537是一个功能性调控变异,通过调节LILRB1表达降低疟疾易感性。
- 非编码变异在疟疾发病机制中发挥作用,抑制性免疫通路是疟疾结局的重要决定因素。
研究设计与样本
- 从非洲eQTL数据集整合连锁不平衡、染色质可及性和转录因子结合 prioritized 调控变异。
- 在267名塞内加尔疟疾或健康个体中对3个非编码变异和1个编码变异进行基因分型,采用校正年龄的logistic回归评估关联。
- 用荧光素酶报告实验评估rs7246537的功能效应。
主要发现
- 仅rs7246537与疟疾显著相关,A等位基因携带者临床疟疾和脑型疟疾风险降低。
- rs7246537与YY1结合位点共定位,荧光素酶实验显示A等位基因驱动较低启动子活性。
临床怎么用
- 该发现提示LILRB1抑制性通路可作为疟疾易感性评估的潜在宿主遗传标志。
- rs7246537功能效应明确,但临床转化需在更大独立队列中验证。
局限性
- 样本量仅267名塞内加尔个体,关联结果需在更大独立人群中验证。
- 研究仅聚焦LILRB1选定变异,未全面评估其他宿主遗传因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malaria remains a major health challenge in sub-Saharan Africa. Host genetic variation influences susceptibility, but the contribution of inhibitory receptors such as LILRB1-targeted by Plasmodium falciparum RIFINs-remains poorly defined. We investigated whether regulatory variants in LILRB1 modulate malaria risk. METHODS: Regulatory variants were prioritized from African expression quantitative trait locus (eQTL) datasets by integrating linkage disequilibrium, chromatin accessibility, and transcription factor binding. Three noncoding variants (rs10416697, rs10423364, and rs7246537) and one coding variant (rs1061680) were selected. Genotyping was performed in 267 Senegalese individuals with malaria or healthy status. Logistic regression adjusted for age assessed genetic associations. The functional effect of rs7246537 was evaluated using luciferase reporter assays. RESULTS: Forty-nine variants were associated with LILRB1 expression in African populations, three overlapping open chromatin near the distal promoter. Only rs7246537 showed significant association with malaria. Carriers of the A allele had reduced risk of clinical malaria and cerebral malaria. rs7246537 colocalized with a YY1-binding site, and luciferase assays demonstrated allele-specific effects, with the A allele driving lower promoter activity. CONCLUSIONS: rs7246537 is a functional regulatory variant that reduces malaria susceptibility by modulating LILRB1 expression, highlighting the role of noncoding variation in malaria pathogenesis. These findings support inhibitory immune pathways as important determinants of malaria outcomes.
引用
- Dieppois C, Chambonnier G, Gallardo F, et al. A Functional Intronic Variant of LILRB1 Associated With Clinical Malaria in the Senegalese Population. J Infect Dis. 2026. PMID: 41492925. doi:10.1093/infdis/jiag007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。